European Journal of Biomedical and Pharmaceutical Sciences

SAFETY AND EFFICACY OF COVID–19 VACCINES ALONG WITH THEIR CONSEQUENCES IN CARDIOVASCULAR AND LIVER PATIENT

Upasana Singh and Dhanesh Kumar*

ABSTRACT

In December 2019, Wuhan (China) reported identifying the first case of the corona virus (COVID-19) pandemic, From that point forward, the corona virus spread quickly worldwide and has gotten a worldwide pandemic, From the month of June 2021, COVID- 19 vaccines have an administrative endorsement in something like one nation, The greater part of these has temporary or emergency authorization just, regularly based on between Phase III clinical trial outcomes, and at times with no accessible distributed clinical trial outcomes, some interesting vaccines have gotten ―Emergency Use Listing (EUL)‖ by the ―WHO‖ such as Covaxin, Covishield, Moderna vaccine and Sputnik V, In healthy individuals and some populations (such as elderly, adults or adolescents), some vaccines are safe and beneficial, particularly against serious illness. Although variant-specific vaccinations are already in development and protection against some variant strains appears to be diminished, based on clinical data, we gave a summary of the clinical findings data relating to the safety and efficacy of the COVID-19 vaccinations as well the effects covid-19 vaccines on patients with liver and cardiovascular systems. Our review article helps for the identifying effectiveness of COVID-19 vaccinations in lowering the disease burden in people with pre-existing liver and cardiovascular conditions. Future research is anticipated to further our grasp of the issue, and a vaccine may be developed specifically for CLD and cardiovascular patients, but until then, the struggle must go on as usual.

Keywords: safety, efficacy, COVID-19 vaccines, liver and CVS Patients.